Vaniprevir
Vaniprevir is a direct-acting antiviral small molecule that competitively inhibits the hepatitis C virus NS3/4A protease, thereby blocking viral replication. It has been utilized in both in vitro enzymatic assays and in vivo animal studies to investigate HCV protease function and antiviral therapy.
Product Specifications
CAS Number
923590-37-8
Product Name Alternative
Vaniprevir, MK7009, MK-7009
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
97.41% (May vary between batches)
Solubility
DMSO:8 mg/mL (10.55 mM)
Smiles
N (C (=O) [C@H]1N2C[C@@] (C1) (OC (=O) N3CC=4C (C3) =CC=CC4CCCCC (C) (C) COC (=O) N[C@@H] ([C@] (C) (C) C) C2=O) [H]) [C@@]5 (C (NS (=O) (=O) C6CC6) =O) [C@H] (CC) C5
Molecular Formula
C38H55N5O9S
Molecular Weight
757.94
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MX892117-01 1 Each
Anti-Mouse CD172a/SIRPA Antibody (SAA0817), FITC
Sign In for Pricing
View Details MX892117-02 100 Tests
Anti-Mouse CD172a/SIRPA Antibody (SAA0817), FITC
Sign In for Pricing
View Details 
035117-ML750 100 µL
Epha2, ID (Epha2, Eck, Myk2, Sek2, Ephrin type-A receptor 2, Epithelial cell kinase, Tyrosine-protein kinase receptor ECK, Tyrosine-protein kinase receptor MPK-5, Tyrosine-protein kinase receptor SEK-2) (MaxLight 750) discontinued
Sign In for Pricing
View Details 